LifeSiteNews has been permanently banned on YouTube. Click HERE to sign up to receive emails when we add to our video library.
OTTAWA, Ontario, March 30, 2021 (LifeSiteNews) – OTTAWA, Ontario, March 30, 2021 (LifeSiteNews) – Canada is pausing the distribution of the AstraZeneca coronavirus jab from being given to people under 55, following numerous reports indicating that the product may be linked to blood clots.
Health Canada, the department of the Government of Canada responsible for national health policy, issued a statement yesterday from the Council of Chief Medical Officers of Health, which includes the Chief Medical Officer of Health from each provincial and territorial jurisdiction, along with Canada’s Chief Public Health Officer.
“As Chief Medical Officers of Health, we are acting decisively with our unified position to pause the use of AstraZeneca vaccine in Canada in those under age 55 at this time. We are taking this precautionary measure while Health Canada as the regulator completes its updated risk/benefit analysis based on emerging data,” the statement reads.
The announcement follows the publication of a report from the National Advisory Committee on Immunization (NACI) which stated that the organization is concerned about the possibility of those who have received the AstraZeneca jab –
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Christian Journal or its editors